South Florida

Integrated Kidney Partners II LLC

Primary Contact

Ryan Pardo
Ryan.Pardo@usrenalcare.com


KCE Participants

Dialysis Facilities

5072020, LLC 70820 Ventures, LLC
USRC Uptown Naples LLC 71120 Ventures, LLC
71020 Ventures, LLC 70920 Ventures, LLC
70620 Partners, LLC 70720 Partners, LLC
USRC Mustang Dialysis, LLC New Smyrna Beach Artificial Kidney, LC

Practices

Associates in Nephrology Butcher & Devacaanthan MD PA

Aastha Parsa Peggy Depalma
Nicole Wilcox Mary Mouracade
Katie Anderson Tamim Ghith
Basudev Pudasaini Neetu Malhotra
Bishal Rawal Robert Libbey
Evan Gross Robert Payne
Joel Vansickler Sourab Dhungel
John Conrey Syeda Khan
Magdala Guerrier

Mogilishetty PLLC

Andrew Nowakowski Beenu Singh
Gautham Mogilishetty Ibrahim Khambati
Meloney Oliveira Kathlin Chou

Independent Practitioner

Christopher Mai

Preferred Providers

Practice Provider Name
Personal Recovery Network LLC
Mogilishetty PLLC Natalia Mysh
Rocky Mountain Kidney Care LLC

Joint Ventures

There are no joint ventures between or among the KCE and any of its KCE Participants and Preferred Providers.


Administrative Lead

Name Employer
Alan St. Pierre U.S. Renal Care

Clinical Lead

Name Employer
Bishal Rawal Associates in Nephrology

KCE Governing Body Members

Name Employer
Alan St. Pierre U.S. Renal Care
Bishal Rawal Associates in Nephrology
Basudev Pudasaini Associates in Nephrology
Natasha Dave Associates in Nephrology
Megan Falkey SVP, VBC, Clinical Ops, U.S. Renal Care
Gautham Mogilishetty Mogilishetty PLLC
Lori Hartwell Consumer Advocate
Stephen Busenlehner U.S. Renal Care

Shared Savings and Shared Losses Information

a. Gross Savings/Losses BEFORE CMS withholds:
PY2022: $1,598,972
PY2023 Shared Savings will be reported in 2026 when final reconciliations are released by CMS.
PY2024: $3,111,105

b. The amount of Shared Savings or Shared Losses, net of CMS Withholds and Aggregation:
PY2022: ($71,294)
PY2023 Shared Savings will be reported in 2026 when final reconciliations are released by CMS.
PY2024: $1,486,929

c. The proportion of Shared Savings invested in infrastructure, redesigned care processes, and other resources necessary to improve outcomes and reduce Medicare costs for Beneficiaries; and
PY2022: N/A
PY2023 Shared Savings will be reported in 2026 when final reconciliations are released by CMS.
PY2024: 99%

d. The proportion of Shared Savings distributed to KCE Participants and Preferred Providers
PY2022: N/A
PY2023 Shared Savings will be reported in 2026 when final reconciliations are released by CMS.
PY2024: 1%

8. The KCE’s performance on the quality measures used to calculate the KCE’s TQS, as described in the Quality Overview Document and Measure Specifications Document.
Total Quality Score (TQS) results out of 100%, based on KCE quality measure performance during the period
Performance Year 2022 TQS: 25%
Performance Year 2023 TQS: 75%
Performance Year 2024 TQS: 100%
Earned High Performance Pool designation

9. Total Program Income to Participants (QCP, Transplant Bonus, Home Bonus, other income)
PY2022: $916,382
PY2023 Ancillary Income will be reported in 2026 when final reconciliations are released by CMS.
PY2024: $1,195,643